Straumann (OTCMKTS:SAUHY) Sets New 12-Month Low - Here's What Happened

Key Points

• 52-week low: Straumann's ADR hit a new 52-week low intraday at $10.00, last trading at $10.25 on volume of 2,490 shares, with the stock reported down about 1.3%.
• Analyst sentiment mixed but weak: Morgan Stanley reiterated an "underweight" and Citigroup a "sell"; overall ratings include one Strong Buy, one Buy, two Hold and two Sell, giving a consensus rating of "Hold."
• Technicals show weakness: the stock is trading below its 50-day simple moving average of $11.95 and its 200-day SMA of $11.73, suggesting continued downward pressure.

Straumann Holding AG (OTCMKTS:SAUHY - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $10.00 and last traded at $10.25, with a volume of 2490 shares trading hands. The stock had previously closed at $10.34.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. Morgan Stanley restated an "underweight" rating on shares of Straumann in a report on Monday, December 15th. Citigroup reissued a "sell" rating on shares of Straumann in a research report on Wednesday, January 14th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have given a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat, Straumann currently has a consensus rating of "Hold".

Straumann Stock Down 1.3%

The company's fifty day simple moving average is $11.95 and its 200 day simple moving average is $11.73.

About Straumann

Straumann OTCMKTS: SAUHY is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company's core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.